BioSpace News Archive

Approach expected to have broad applications in agriculture, industrial biotechnology, human healthcare

CohBar, Inc. announced that its Chief Executive Officer, Steven Engle, will present a company update at the 2020 BIO CEO & Investor Conference, which is being held February 10-11 at the Marriott Marquis in New York.

Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today the Executive Steering Committee for its fully retrievable transfemoral trans-septal Tiara™ (“TF/TS Tiara”) program.

RSIP Vision, a global leader in artificial intelligence (AI) and computer vision technology, announced today a new innovative AI-based Shoulder Replacement Solution that will be integrated into leading vendors’ Surgery Planning Platforms

Cano Health, LLC, a leading population health management company and operator of primary care medical centers in Florida, is thrilled to announce that it has acquired certain assets of the operations of Primary Care Physicians of Hollywood (PCP), one of the largest and most sought-after providers of medical care for seniors in South Florida.

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Clonidine Hydrochloride Extended-Release Tablets in 0.1 mg strength. Upsher-Smith’s product is AB1-rated to the branded product, KAPVAY® (clonidine hydrochloride) extended-release tablets

The Muscular Dystrophy Association (MDA) named 10-year-old Ethan LyBrand as its 2020-2021 MDA National Ambassador.

Enzychem Lifesciences, a leading global biopharmaceutical company focusing on innovative new drug development for unmet medical needs, today announced that Dr. Michael Charlton, an internationally renowned specialist in liver diseases and transplant medicine, has joined its Scientific Advisory Board.

FACIT, a commercialization venture firm focused on advancing Ontario’s top-tier oncology innovations, announced new follow-on investments in start-ups Xpan Inc. (“Xpan”) and Nanology Labs (“Nanology”).

Ed Ikeguchi, M.D. Named AiCure’s First President Founder and Board member Adam Hanina Assumes Role as Head of Special Projects.